Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis.

Shanker M, Chua B, Bettington C, Foote MC, Pinkham MB.

Neurooncol Pract. 2019 Mar;6(2):144-155. doi: 10.1093/nop/npy019. Epub 2018 Jun 14.

PMID:
31386038
2.

Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.

Gigliotti MJ, Hasan S, Karlovits SM, Ranjan T, Wegner RE.

Stereotact Funct Neurosurg. 2018;96(5):289-295. doi: 10.1159/000493545. Epub 2018 Nov 7.

PMID:
30404102
3.

Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

Palmer JD, Bhamidipati D, Song A, Eldredge-Hindy HB, Siglin J, Dan TD, Champ CE, Zhang I, Bar-Ad V, Kim L, Glass J, Evans JJ, Andrews DW, Werner-Wasik M, Shi W.

J Neurooncol. 2018 Dec;140(3):623-628. doi: 10.1007/s11060-018-2989-z. Epub 2018 Sep 4.

PMID:
30182159
4.

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.

Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR.

J Neurooncol. 2016 May;127(3):535-9. doi: 10.1007/s11060-016-2059-3. Epub 2016 Jan 29.

PMID:
26821711
5.

Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.

Verma J, McCutcheon IE, Waguespack SG, Mahajan A.

Pituitary. 2014 Dec;17(6):539-45. doi: 10.1007/s11102-013-0541-x.

PMID:
24272035
6.

Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.

Maranzano E, Anselmo P, Casale M, Trippa F, Carletti S, Principi M, Loreti F, Italiani M, Caserta C, Giorgi C.

Tumori. 2011 Jan-Feb;97(1):56-61.

PMID:
21528665
7.

Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.

Hashmi A, Guckenberger M, Kersh R, Gerszten PC, Mantel F, Grills IS, Flickinger JC, Shin JH, Fahim DK, Winey B, Oh K, John Cho BC, Létourneau D, Sheehan J, Sahgal A.

J Neurosurg Spine. 2016 Nov;25(5):646-653. Epub 2016 Jun 24.

PMID:
27341054
8.

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW.

J Neurooncol. 2018 Mar;137(1):171-177. doi: 10.1007/s11060-017-2709-0. Epub 2017 Dec 12. Erratum in: J Neurooncol. 2018 Jan 8;:.

PMID:
29235052
9.

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1133-41.

PMID:
10613305
10.

External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain.

Sminia P, Mayer R.

Cancers (Basel). 2012 Apr 5;4(2):379-99. doi: 10.3390/cancers4020379.

11.

Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.

Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J, Schulz-Ertner D.

J Neurooncol. 2008 Sep;89(2):205-10. doi: 10.1007/s11060-008-9607-4. Epub 2008 May 7.

PMID:
18461281
12.

Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.

Persson O, Bartek J Jr, Shalom NB, Wangerid T, Jakola AS, Förander P.

Acta Neurochir (Wien). 2017 Jun;159(6):1013-1021. doi: 10.1007/s00701-017-3164-6. Epub 2017 Apr 13. Review.

13.

Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.

Fatima N, Meola A, Pollom EL, Soltys SG, Chang SD.

Neurosurg Focus. 2019 Jun 1;46(6):E2. doi: 10.3171/2019.3.FOCUS1970.

PMID:
31153149
14.

Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.

Combs SE, Edler L, Rausch R, Welzel T, Wick W, Debus J.

Acta Oncol. 2013 Jan;52(1):147-52. doi: 10.3109/0284186X.2012.692882. Epub 2012 Jun 11.

PMID:
22686472
15.

Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy.

Murai T, Sato K, Iwabuchi M, Manabe Y, Ogino H, Iwata H, Tatewaki K, Yokota N, Ohta S, Shibamoto Y.

Jpn J Radiol. 2016 Mar;34(3):211-8. doi: 10.1007/s11604-015-0511-5. Epub 2015 Dec 18. Erratum in: Jpn J Radiol. 2016 Mar;34(3):219.

PMID:
26682738
16.

Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.

Rana N, Pendyala P, Cleary RK, Luo G, Zhao Z, Chambless LB, Cmelak AJ, Attia A, Stavas MJ.

Front Oncol. 2017 Nov 23;7:279. doi: 10.3389/fonc.2017.00279. eCollection 2017.

17.

Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.

Kim DH, Schultheiss TE, Radany EH, Badie B, Pezner RD.

J Neurooncol. 2013 Oct;115(1):37-43. doi: 10.1007/s11060-013-1191-6. Epub 2013 Jun 28.

PMID:
23813230
18.

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.

Combs SE, Burkholder I, Edler L, Rieken S, Habermehl D, Jäkel O, Haberer T, Haselmann R, Unterberg A, Wick W, Debus J.

BMC Cancer. 2010 Oct 6;10:533. doi: 10.1186/1471-2407-10-533.

19.

Radiotherapy for diffuse brainstem glioma in children and young adults.

Hu X, Fang Y, Hui X, Jv Y, You C.

Cochrane Database Syst Rev. 2016 Jun 27;(6):CD010439. doi: 10.1002/14651858.CD010439.pub2. Review.

PMID:
27378212
20.

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM.

Radiat Oncol. 2011 May 15;6:48. doi: 10.1186/1748-717X-6-48.

Supplemental Content

Support Center